146 related articles for article (PubMed ID: 31382912)
21. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
22. Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia.
Wang M; Shen L; Xu X; Duan W; Miao J; Kong W; Su L; Wu Y
Biomed Res Int; 2021; 2021():6661698. PubMed ID: 34258277
[TBL] [Abstract][Full Text] [Related]
23. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
24. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Savage P; Kelpanides I; Tuthill M; Short D; Seckl MJ
Gynecol Oncol; 2015 Apr; 137(1):73-6. PubMed ID: 25598530
[TBL] [Abstract][Full Text] [Related]
27. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
28. Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management.
Markman M
J Cancer Res Clin Oncol; 2004 Jul; 130(7):383-7. PubMed ID: 15150657
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
Xiao H; Mazumdar M; Bajorin DF; Sarosdy M; Vlamis V; Spicer J; Ferrara J; Bosl GJ; Motzer RJ
J Clin Oncol; 1997 Jul; 15(7):2553-8. PubMed ID: 9215824
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
[TBL] [Abstract][Full Text] [Related]
32. Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
Kanno T; Matsui H; Akizawa Y; Usui H; Shozu M
J Gynecol Oncol; 2018 Nov; 29(6):e89. PubMed ID: 30207097
[TBL] [Abstract][Full Text] [Related]
33. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis.
Li J; Yue H; Wang X; Chen R; Lu X
Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():164-169. PubMed ID: 31136884
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
36. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Mora PAR; Sun SY; Velarde GC; Filho JR; Uberti EH; Dos Santos Esteves APV; Elias KM; Horowitz NS; Braga A; Berkowitz RS
Gynecol Oncol; 2019 May; 153(2):277-285. PubMed ID: 30857648
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
38. Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
Rathod PS; Kundargi R; Pallavi VR; Vijay CR; Devi UK; Bafna UD
Int J Gynecol Cancer; 2015 Nov; 25(9):1737-41. PubMed ID: 26401644
[TBL] [Abstract][Full Text] [Related]
39. BEP for high-risk gestational trophoblastic tumor: results from a cohort of 45 patients.
Song SQ; Wang C; Zhang GN; Shi Y; Zhu Y; Hu T; Xu SQ; Yang ZR
Eur J Gynaecol Oncol; 2015; 36(6):726-9. PubMed ID: 26775361
[TBL] [Abstract][Full Text] [Related]
40. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
